Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma

NCT05123131 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Isatuximab
DRUG: Bortezomib
DRUG: Lenalidomide
DRUG: Dexamethasone (IV)

Sponsor

Cancer Trials Ireland

Collaborators

[object Object]
[object Object]